|
|
Patients |
Controls |
Significance |
Clinic |
Number |
66 |
25 |
|
|
Age MV |
MV 40.04 |
MV 30.96 |
p=0.001 |
|
Gender male % |
65.3% |
56.0% |
p=0.474 |
|
Smoker former % |
69.4% |
64.0% |
p=0.626 |
|
Smoker current % |
33.3% |
48.0% |
p=0.232 |
|
Allergy % |
26.4% |
16.0% |
p=0.415 |
|
Asthma % |
2% |
26.4% |
p=0,.088 |
|
N-ERD % |
8.3% |
0% |
p=0.334 |
Laboratory Findings |
Eotaxin/ CCL11 pg/ml |
MV 37.98 |
MV
11.68 |
p=0.002 |
|
MCP-3/ CCL7 pg/ml |
MV 3.98 |
MV 5.73 |
p=0.226 |
|
MIP-1α/ CCL3pg/ ml |
MV 4.18 |
MV 5.94 |
p=0.334 |
|
ENA-78/ CXCL5pg/ml |
MV 43.97 |
MV 113.19 |
p=0.063 |
|
TARC/ CCL17 pg/ml |
MV 8.42 |
MV 5.86 |
p=0.000 |
|
PARC/ CCL18pg/ml |
MV 383.61 |
MV 119.03 |
p=0.038 |
|
IP-10/CXCL10 pg/ml |
MV 424.12 |
MV 274.25 |
p=0.287 |
|
Total IgE kU/l |
MV 337.34 |
MV 30.00 |
p=0.002 |
|
ECP pg/ml |
MV 5122.77 |
MV 194.37 |
p=0.000 |
|
IL-5 pg/ml |
MV 412.83 |
MV 2.91 |
p=0.000 |
|
SAE kU/l |
MV 8.34 |
MV 0.00 |
p=0.073 |
|
IL-22 pg/ml |
MV 629.97 |
MV 484.64 |
p=0.283 |
|
TNF-α pg/ml |
MV 13.29 |
MV 10.06 |
p=0.715 |
|
IL-17 pg/ml |
MV 14.56 |
MV 14.49 |
p=0.067 |
|
IFN-γ pg/ml |
MV 55.23 |
MV 163.51 |
p=0.227 |